Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.

Hoang, Phuong; Hurtubise, Brigitte; Muppidi, Srikanth

Hoang, Phuong; Hurtubise, Brigitte; Muppidi, Srikanth.

Hoang P; From the Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA. pthoang@stanford.edu.
Hurtubise B; From the Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA.
Muppidi S; From the Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA.

Neurology ; 95(18): 840-843, 2020 11 03.

Article in English | MEDLINE | ID: covidwho-975950

Subject(s)

Betacoronavirus/pathogenicity; Coronavirus Infections/complications; Coronavirus Infections/therapy; Myasthenia Gravis/complications; Myasthenia Gravis/therapy; Pneumonia, Viral/complications; Pneumonia, Viral/therapy; COVID-19; Female; Humans; Middle Aged; Myasthenia Gravis/drug therapy; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus / Myasthenia Gravis Type of study: Case report / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Journal: Neurology Year: 2020 Document Type: Article Affiliation country: Wnl.0000000000010651

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google